Sagimet Biosciences Inc. (SGMT)
$7.98-9.32%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $260M
- Beta
- 3.49
- P/E (TTM)
- -6.23
- Short % float
- 35.85%
- Days to cover
- 6.7
- SI change
- +9.0%
- 1W
- -8.90%
- 1M
- -26.65%
- vs SPY 1W
- -8.77%
- vs SPY 1M
- -29.16%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SGMT?
- LOPJLB’s latest quantitative signal on Sagimet Biosciences Inc. (SGMT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SGMT in?
- Sagimet Biosciences Inc. (SGMT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sagimet Biosciences Inc. (SGMT) do?
- Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The companyâs lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dy…